Development of approaches for cellular immunotherapy of cancer patients

Development of approaches for cellular immunotherapy of cancer patients

To treat the patients with oncological diseases, cellular immunotherapy have been actively developed in recent years. Usage of antitumor adoptive immunotherapy (AIT) based on in vitro activated lymphocytes and natural killer cells (NK cells) is the most urgent issue. Their antitumor potential is enh...

Full description

Bibliographic Details
Main Authors:	Yu. V. Gelm, E. V. Abakushina, I. A. Pasova, L. Yu. Grivtsova
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2021-05-01
Series:	Медицинская иммунология
Subjects:	lymphocytes in vitro activation il-2 il-12 il-15 cell immunotherapy cell's activity physiological reserve
Online Access:	https://www.mimmun.ru/mimmun/article/view/2135

Similar Items

Heterodimeric IL-15 in Cancer Immunotherapy
by: Cristina Bergamaschi, et al.
Published: (2021-02-01)

IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development in vivo
by: Margherita Boieri, et al.
Published: (2017-03-01)

The role of cytokine in regulation of the natural killer cell activity
by: Jurišić Vladimir, et al.
Published: (2008-01-01)

A novel multimeric IL15/IL15Rα-Fc complex to enhance cancer immunotherapy
by: Hong Xu, et al.
Published: (2021-01-01)

The emerging role of SNARE proteins in dendritic cell function
by: Laura E Collins, et al.
Published: (2015-03-01)

IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells
by: Andreas A. Hombach, et al.
Published: (2020-04-01)

The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation
by: Annekathrin Heinze, et al.
Published: (2019-12-01)

Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma
by: Ian Lai, et al.
Published: (2018-11-01)

Dendritic cell derived cytokines in human natural killer cell differentiation and activation
by: Obinna eChijioke, et al.
Published: (2013-11-01)

An In-Vitro Study of the Expansion and Transcriptomics of CD<sup>4+</sup> and CD<sup>8+</sup> Naïve and Memory T Cells Stimulated by IL-2, IL-7 and IL-15
by: Brooks Hopkins, et al.
Published: (2022-05-01)

Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapy
by: Yona Levites, et al.
Published: (2021-05-01)

SECRETION OF IL-12, IL-27 BY MONONUCLEAR LEUKOCYTES AND EXPRESSION OF THEIR RECEPTORS ON T-LYMPHOCYTES IN CONDITIONS OF DIRECTED CELL INDUCTION IN VITRO IN PULMONARY TUBERCULOSIS
by: I. E. Esimova, et al.
Published: (2014-08-01)

Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family
by: Hideaki Hasegawa, et al.
Published: (2016-11-01)

Memory-Like NK Cells: Remembering a Previous Activation by Cytokines and NK Cell Receptors
by: Jens H. W. Pahl, et al.
Published: (2018-11-01)

Immune response to biological therapy for inflammatory bowel diseases
by: O V Kniazev, et al.
Published: (2013-12-01)

Efbalropendekin Alfa enhances human natural killer cell cytotoxicity against tumor cell lines in vitro
by: Hesham M. Shehata, et al.
Published: (2024-03-01)

IL-15 Enhances the Persistence and Function of BCMA-Targeting CAR-T Cells Compared to IL-2 or IL-15/IL-7 by Limiting CAR-T Cell Dysfunction and Differentiation
by: Anthony M. Battram, et al.
Published: (2021-07-01)

Transcriptional Regulation of Natural Killer Cell Development and Functions
by: Dandan Wang, et al.
Published: (2020-06-01)

IL-2 and IL-15 dependent thymic development of Foxp3-expressing regulatory T lymphocytes
by: Cécile Apert, et al.
Published: (2017-05-01)

IL-15 negatively regulates curdlan-induced IL-23 production by human monocyte-derived dendritic cells and subsequent Th17 response
by: Ahmet Eken, et al.
Published: (2019-11-01)

POSSIBLE MECHANISMS OF STIMULATORY EFFECTS OF MESENCHYMAL STROMAL CELLS UPON T CELL RECOVERY DURING CHEMOTHERAPY-INDUCED LYMPHOPENIA
by: E. V. Batorov, et al.
Published: (2014-08-01)

NK Cell IL-10 Production Requires IL-15 and IL-10 Driven STAT3 Activation
by: Sarah E. Clark, et al.
Published: (2019-09-01)

Cytokine Gene Vaccine Therapy for Treatment of a Brain Tumor
by: Terry Lichtor, et al.
Published: (2023-10-01)

Electrotransfer of IL-15/IL-15Rα Complex for the Treatment of Established Melanoma
by: Shawna A. Shirley, et al.
Published: (2020-10-01)

Ancient Cytokine Interleukin 15-Like (IL-15L) Induces a Type 2 Immune Response
by: Takuya Yamaguchi, et al.
Published: (2020-10-01)

Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma
by: Gabeen AA, et al.
Published: (2014-06-01)

New Approaches in Immunotherapy of Behçet Disease
by: Behzad Baradaran, et al.
Published: (2013-02-01)

The Role of IL-7 and IL-7R in Cancer Pathophysiology and Immunotherapy
by: Chunli Wang, et al.
Published: (2022-09-01)

DEVELOPMENT OF A REAL-TIME RT-PCR-BASED TEST PANEL FOR ASSESSMENT OF CYTOKINE PROFILE IN MONONUCLEAR CELLS FROM BLOOD AND SYNOVIAL FLUID IN RHEUMATOID ARTHRITIS
by: D. Yu. Trofimov, et al.
Published: (2014-07-01)

Lung cancer cell-intrinsic IL-15 promotes cell migration and sensitizes murine lung tumors to anti-PD-L1 therapy
by: Shaojie Hu, et al.
Published: (2024-04-01)

Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand
by: Galy Anne, et al.
Published: (2002-10-01)

The multifaceted role of IL-12 in cancer
by: Um e Habiba, et al.
Published: (2022-10-01)

IL-33 Enhances IFNγ and TNFα Production by Human MAIT Cells: A New Pro-Th1 Effect of IL-33
by: Mourad Azzout, et al.
Published: (2021-09-01)

The roles of different forms of IL-15 in human melanoma progression
by: Sabina Di Matteo, et al.
Published: (2023-06-01)

Immunotherapy for Visceral Leishmaniasis: Ability of Factors Produced during Anti-leishmania Responses of Skin Test Positive Adults to Inhibit Peripheral Blood Mononuclear Cell Activities Associated with Visceral Leishmaniasis
by: Holaday Bettie J
Published: (1999-01-01)

Encephalitozoon intestinalis inhibits dendritic cell differentiation through an IL-6-dependent mechanism
by: Carmen Elisa Bernal Silva, et al.
Published: (2016-02-01)

The Effect of Homocysteine on the Secretion of Il-1β, Il-6, Il-10, Il-12 and RANTES by Peripheral Blood Mononuclear Cells—An In Vitro Study
by: Magdalena Borowska, et al.
Published: (2021-11-01)

Evaluation of In Vitro Production of IFN-γ, IL-10, IL-12 and IL-13 by Blood Cells in Patients with Cutaneous Leishmaniasis Lesions
by: Majid Mahmoodi, et al.
Published: (2005-03-01)

IL-12 and IL-23—Close Relatives with Structural Homologies but Distinct Immunological Functions
by: Doreen M. Floss, et al.
Published: (2020-09-01)

Treatment of aggressive T-cell lymphoma/leukemia with anti-CD4 CAR T cells
by: Jia Feng, et al.
Published: (2022-09-01)